![Mechanisms of action of thalidomide and CC-5013 targeting MM cells and... | Download Scientific Diagram Mechanisms of action of thalidomide and CC-5013 targeting MM cells and... | Download Scientific Diagram](https://www.researchgate.net/profile/Lucia-Farina/publication/7964514/figure/fig2/AS:277681968041993@1443215948870/Mechanisms-of-action-of-thalidomide-and-CC-5013-targeting-MM-cells-and-the-BM.png)
Mechanisms of action of thalidomide and CC-5013 targeting MM cells and... | Download Scientific Diagram
![Thalidomide for the treatment of multiple myeloma - Hattori - 2004 - Congenital Anomalies - Wiley Online Library Thalidomide for the treatment of multiple myeloma - Hattori - 2004 - Congenital Anomalies - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/bd72ec43-3389-4f36-9c49-ecd4f37d0829/cga_025_f4.gif)
Thalidomide for the treatment of multiple myeloma - Hattori - 2004 - Congenital Anomalies - Wiley Online Library
![Mechanism of thalidomide on MM cells. Thalidomide arrests MM cells in... | Download Scientific Diagram Mechanism of thalidomide on MM cells. Thalidomide arrests MM cells in... | Download Scientific Diagram](https://www.researchgate.net/profile/Miao-Xu-7/publication/249647884/figure/fig2/AS:667104411918337@1536061494118/Mechanism-of-thalidomide-on-MM-cells-Thalidomide-arrests-MM-cells-in-the-G-1-phase-by.jpg)
Mechanism of thalidomide on MM cells. Thalidomide arrests MM cells in... | Download Scientific Diagram
![Mechanism of action of lenalidomide in hematological malignancies | Journal of Hematology & Oncology | Full Text Mechanism of action of lenalidomide in hematological malignancies | Journal of Hematology & Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1756-8722-2-36/MediaObjects/13045_2009_Article_63_Fig3_HTML.jpg)
Mechanism of action of lenalidomide in hematological malignancies | Journal of Hematology & Oncology | Full Text
![Frontiers | Understanding the Role of T-Cells in the Antimyeloma Effect of Immunomodulatory Drugs | Immunology Frontiers | Understanding the Role of T-Cells in the Antimyeloma Effect of Immunomodulatory Drugs | Immunology](https://www.frontiersin.org/files/Articles/632399/fimmu-12-632399-HTML/image_m/fimmu-12-632399-g001.jpg)
Frontiers | Understanding the Role of T-Cells in the Antimyeloma Effect of Immunomodulatory Drugs | Immunology
![Renal Toxicities of Novel Agents Used for Treatment of Multiple Myeloma | American Society of Nephrology Renal Toxicities of Novel Agents Used for Treatment of Multiple Myeloma | American Society of Nephrology](https://cjasn.asnjournals.org/content/12/1/176/F1.large.jpg)
Renal Toxicities of Novel Agents Used for Treatment of Multiple Myeloma | American Society of Nephrology
![Pomalidomide – An Appraisal of Its Clinical Development and Role in the Treatment of Relapsed/Refractory Multiple Myeloma - touchONCOLOGY Pomalidomide – An Appraisal of Its Clinical Development and Role in the Treatment of Relapsed/Refractory Multiple Myeloma - touchONCOLOGY](https://touchoncology.com/wp-content/uploads/sites/2/2015/12/The_Antimyeloma_Immunomodulatory_and_Stromal-support_Inhibitory.png)
Pomalidomide – An Appraisal of Its Clinical Development and Role in the Treatment of Relapsed/Refractory Multiple Myeloma - touchONCOLOGY
![Proposed mechanisms of action of thalidomide upon tumorous plasma cell... | Download Scientific Diagram Proposed mechanisms of action of thalidomide upon tumorous plasma cell... | Download Scientific Diagram](https://www.researchgate.net/profile/Lisa-Arfons/publication/236106954/figure/fig4/AS:299544559538179@1448428396649/Proposed-mechanisms-of-action-of-thalidomide-upon-tumorous-plasma-cell-and-surrounding.png)
Proposed mechanisms of action of thalidomide upon tumorous plasma cell... | Download Scientific Diagram
![References in Thalidomide for Patients With Relapsed Multiple Myeloma After High-Dose Chemotherapy and Stem Cell Transplantation: Results of an Open-Label Multicenter Phase 2 Study of Efficacy, Toxicity, and Biological Activity - Mayo References in Thalidomide for Patients With Relapsed Multiple Myeloma After High-Dose Chemotherapy and Stem Cell Transplantation: Results of an Open-Label Multicenter Phase 2 Study of Efficacy, Toxicity, and Biological Activity - Mayo](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/59782/353662/gr1.jpg)
References in Thalidomide for Patients With Relapsed Multiple Myeloma After High-Dose Chemotherapy and Stem Cell Transplantation: Results of an Open-Label Multicenter Phase 2 Study of Efficacy, Toxicity, and Biological Activity - Mayo
![Frontiers | Thalidomide-Revisited: Are COVID-19 Patients Going to Be the Latest Victims of Yet Another Theoretical Drug-Repurposing? | Immunology Frontiers | Thalidomide-Revisited: Are COVID-19 Patients Going to Be the Latest Victims of Yet Another Theoretical Drug-Repurposing? | Immunology](https://www.frontiersin.org/files/Articles/549261/fimmu-11-01248-HTML/image_m/fimmu-11-01248-g001.jpg)